Sachi Horibata

2.2k total citations
31 papers, 1.6k citations indexed

About

Sachi Horibata is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Sachi Horibata has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Oncology and 9 papers in Immunology. Recurrent topics in Sachi Horibata's work include PARP inhibition in cancer therapy (4 papers), Immune Cell Function and Interaction (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Sachi Horibata is often cited by papers focused on PARP inhibition in cancer therapy (4 papers), Immune Cell Function and Interaction (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Sachi Horibata collaborates with scholars based in United States, Canada and France. Sachi Horibata's co-authors include Scott A. Coonrod, Arvinder Kapur, Manish S. Patankar, Paul R. Thompson, John L. McElwee, Mildred Felder, Sunish Mohanan, Brian D. Cherrington, Hadi Shojaei and Lucas Fass and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and PLoS ONE.

In The Last Decade

Sachi Horibata

30 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sachi Horibata United States 16 838 550 477 281 154 31 1.6k
Venkatesh Krishnan United States 20 1.1k 1.3× 961 1.7× 758 1.6× 285 1.0× 149 1.0× 35 2.3k
Jean S. Beebe United States 19 636 0.8× 415 0.8× 314 0.7× 142 0.5× 65 0.4× 39 1.7k
Julia V. Burnier Canada 21 592 0.7× 174 0.3× 408 0.9× 318 1.1× 93 0.6× 73 1.2k
Xuesong Yang China 20 715 0.9× 308 0.6× 361 0.8× 390 1.4× 65 0.4× 33 1.2k
Sara Ricardo Portugal 22 879 1.0× 219 0.4× 874 1.8× 487 1.7× 80 0.5× 54 1.7k
Xin He China 27 1.3k 1.6× 500 0.9× 456 1.0× 576 2.0× 142 0.9× 132 2.4k
Maria Rosa Bani Italy 28 1.6k 1.9× 384 0.7× 789 1.7× 509 1.8× 143 0.9× 62 2.4k
Deborah A. Zajchowski United States 26 1.3k 1.5× 224 0.4× 708 1.5× 319 1.1× 76 0.5× 38 2.0k
Imayavaramban Lakshmanan United States 27 1.5k 1.7× 504 0.9× 961 2.0× 407 1.4× 70 0.5× 43 2.2k
Xinhui Wang United States 21 828 1.0× 536 1.0× 917 1.9× 459 1.6× 52 0.3× 55 1.9k

Countries citing papers authored by Sachi Horibata

Since Specialization
Citations

This map shows the geographic impact of Sachi Horibata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sachi Horibata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sachi Horibata more than expected).

Fields of papers citing papers by Sachi Horibata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sachi Horibata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sachi Horibata. The network helps show where Sachi Horibata may publish in the future.

Co-authorship network of co-authors of Sachi Horibata

This figure shows the co-authorship network connecting the top 25 collaborators of Sachi Horibata. A scholar is included among the top collaborators of Sachi Horibata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sachi Horibata. Sachi Horibata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guha, Avirup, Fei Fang, Qianyi Wang, et al.. (2025). AI-driven prediction of cardio-oncology biomarkers through protein corona analysis. Chemical Engineering Journal. 509. 161134–161134. 3 indexed citations
2.
Rattan, Ramandeep, et al.. (2025). GPT2 mediates glutamine metabolism-driven metabolic alterations in platinum-resistant ovarian cancer cells. Scientific Reports. 15(1). 30528–30528.
3.
Sanderson, Saskia C., et al.. (2024). Ovarian tumor microenvironment contributes to tumor progression and chemoresistance. Cancer Drug Resistance. 7. 53–53. 3 indexed citations
4.
Mukai, Chinatsu, et al.. (2023). GDNF-RET signaling and EGR1 form a positive feedback loop that promotes tamoxifen resistance via cyclin D1. BMC Cancer. 23(1). 138–138. 11 indexed citations
5.
Horibata, Sachi, et al.. (2022). Mechanisms of chemotherapy resistance in ovarian cancer. Cancer Drug Resistance. 5(2). 304–316. 75 indexed citations
6.
Huang, Tzu‐Ting, et al.. (2022). Cell cycle checkpoints and beyond: Exploiting the ATR/CHK1/WEE1 pathway for the treatment of PARP inhibitor–resistant cancer. Pharmacological Research. 178. 106162–106162. 73 indexed citations
7.
Robey, Robert W., et al.. (2021). ATP-binding cassette transporters at the zebrafish blood-brain barrier and the potential utility of the zebrafish as an in vivo model. Cancer Drug Resistance. 4. 620–633. 10 indexed citations
8.
Horibata, Sachi, et al.. (2020). Host gene expression modulated by Zika virus infection of human-293 cells. Virology. 552. 32–42. 7 indexed citations
9.
Maher, Frances A., et al.. (2020). Cross-resistance of cisplatin selected cells to anti-microtubule agents: Role of general survival mechanisms. Translational Oncology. 14(1). 100917–100917. 11 indexed citations
10.
Horibata, Sachi, et al.. (2020). The Evolving AML Genomic Landscape: Therapeutic Implications. Current Cancer Drug Targets. 20(7). 532–544. 9 indexed citations
11.
Huff, Lyn M., Sachi Horibata, Robert W. Robey, Matthew D. Hall, & Michael M. Gottesman. (2019). Mycoplasma Infection Mediates Sensitivity of Multidrug-Resistant Cell Lines to Tiopronin: A Cautionary Tale. Journal of Medicinal Chemistry. 63(3). 1434–1439. 5 indexed citations
12.
Horibata, Sachi, Edward J. Rice, Chinatsu Mukai, et al.. (2018). ER-positive breast cancer cells are poised for RET-mediated endocrine resistance. PLoS ONE. 13(4). e0194023–e0194023. 17 indexed citations
13.
Horibata, Sachi, Katherine E. Rogers, Lynne J. Anguish, et al.. (2017). Role of peptidylarginine deiminase 2 (PAD2) in mammary carcinoma cell migration. BMC Cancer. 17(1). 378–378. 38 indexed citations
14.
Mohanan, Sunish, Sachi Horibata, Lynne J. Anguish, et al.. (2017). PAD2 overexpression in transgenic mice augments malignancy and tumor-associated inflammation in chemically initiated skin tumors. Cell and Tissue Research. 370(2). 275–283. 11 indexed citations
15.
Vo, Tommy V., Jishnu Das, Michael J. Meyer, et al.. (2016). A Proteome-wide Fission Yeast Interactome Reveals Network Evolution Principles from Yeasts to Human. Cell. 164(1-2). 310–323. 74 indexed citations
16.
Horibata, Sachi, Tommy V. Vo, Venkataraman Subramanian, Paul R. Thompson, & Scott A. Coonrod. (2015). Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells. Journal of Visualized Experiments. e52727–e52727. 122 indexed citations
17.
McElwee, John L., Sunish Mohanan, Sachi Horibata, et al.. (2014). PAD2 Overexpression in Transgenic Mice Promotes Spontaneous Skin Neoplasia. Cancer Research. 74(21). 6306–6317. 32 indexed citations
18.
Mohanan, Sunish, Sachi Horibata, John L. McElwee, Andrew J. Dannenberg, & Scott A. Coonrod. (2013). Identification of Macrophage Extracellular Trap-Like Structures in Mammary Gland Adipose Tissue: A Preliminary Study. Frontiers in Immunology. 4. 67–67. 99 indexed citations
19.
Gubbels, Jennifer A. A., Brian Gadbaw, Ilia N. Buhtoiarov, et al.. (2011). Ab-IL2 fusion proteins mediate NK cell immune synapse formation by polarizing CD25 to the target cell-effector cell interface. Cancer Immunology Immunotherapy. 60(12). 1789–1800. 34 indexed citations
20.
Belisle, Jennifer A., Sachi Horibata, Sarah Petrie, et al.. (2010). Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes. Molecular Cancer. 9(1). 118–118. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Venkatesh Krishnan Breakdown of academic impact, for papers by Jean S. Beebe Breakdown of academic impact, for papers by Julia V. Burnier Breakdown of academic impact, for papers by Xuesong Yang Breakdown of academic impact, for papers by Sara Ricardo Breakdown of academic impact, for papers by Xin He Breakdown of academic impact, for papers by Maria Rosa Bani Breakdown of academic impact, for papers by Deborah A. Zajchowski Breakdown of academic impact, for papers by Imayavaramban Lakshmanan Breakdown of academic impact, for papers by Xinhui Wang
Rankless by CCL
2026